Stage 1 mesothelioma is localized. The cancer is confined to one side of the chest lining or one area of the abdomen and has not spread to lymph nodes or distant organs. At this stage, treatment may ...

Oslo, Norway, 17 February 2026 – Oncoinvent, a biotech developing a receptor-independent alpha radiopharmaceutical to ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...

The Phase 1 SPARC trial evaluates safety, tolerability, and pharmacokinetics across multiple OPT101 concentrations during ...

A companion diagnostic test was simultaneously approved to identify eligible patients whose tumors express PD-L1 with a combined positive score of 1 or higher.

TIRUCHY: Following a major scale-up of renal services for the past seven to eight years, Mahatma Gandhi Memorial Government ...

Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic ...

Agilent Technologies, Inc. (NYSE:A) is one of the 10 best life sciences stocks to buy according to hedge funds. On February ...

Can artificial intelligence (AI) tools reliably handle the complexity and nuance of cancer care? A new systematic evaluation from Shanghai places that question under rigorous clinical scrutiny, ...

The efficacy and safety of donafenib-containing regimens as postoperative adjuvant therapy for hepatocellular carcinoma (HCC): A multicenter retrospective study. This is an ASCO Meeting Abstract from ...

Johnson & Johnson's stock hits a 52-week high, but key drug patent risks and a lower Wall Street price target suggest downside. Learn more about JNJ stock here.